查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1713622

2025年預測與預測測試全球市場報告

Predictive And Presymptomatic Testing Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 175 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

預計未來幾年預測和預兆測試的市場規模將快速成長。到 2029 年，這一數字將成長至 84.7 億美元，複合年成長率為 10.1%。預測期內的成長可歸因於對疾病早期檢測的需求不斷增加、對生物技術和基因組學的投資不斷增加、對非侵入性檢測方法的需求不斷增加、老年人口不斷成長以及對精準醫療的不斷努力。預測期內的關鍵趨勢包括個人化醫療的採用、家庭檢測套組的採用、基因組學和巨量資料的整合、次世代定序(NGS) 技術的開發以及藥物開發中預測測試的引入。

預計遺傳疾病盛行率的不斷上升將推動未來幾年預測和預後測試市場的擴張。由去氧核糖核酸（DNA）異常（例如基因突變或染色體改變）引起的遺傳性疾病包括囊腫纖維化和唐氏症等疾病。導致這些疾病發生率增加的因素包括母親老化、環境影響和診斷技術的改進。透過在症狀出現之前識別高風險個體，預測性和預測性測試對於降低遺傳疾病的發生率至關重要。這種積極主動的策略允許早期療育和改變生活方式，有助於預防或減輕這些疾病的嚴重程度。例如，2023年6月，美國非營利醫療和科學組織美國基因與細胞治療學會報告稱，2023年第三季度，處於III期臨床試驗的基因治療藥物數量增加了10%，這是自2022年第三季度以來的首次季度成長。因此，遺傳疾病盛行率的上升正在推動預測和預後檢測市場的成長。

預測和預測測試市場的主要企業正在優先考慮技術進步，例如微生物組驅動的預測模型，以改善早期檢測並提供個人化的健康見解。這些預測模型利用微生物組數據來預測潛在的健康問題並增強早期診斷。例如，2023年12月，印度生技公司Genefitletics推出了突破性的心血管疾病（CVD）預測模型vascomath。此模型利用腸道和口腔微生物組的基因表現數據來早期檢測心血管風險。該模型將與現有的預測模型相結合，提供精準的營養干預，代表預測和預後測試的重大創新。

目錄

第1章執行摘要

第2章 市場特徵

第3章 市場趨勢與策略

第4章 市場：宏觀經濟情景，包括利率、通膨、地緣政治、新冠疫情、經濟復甦對市場的影響

第5章 全球成長分析與策略分析框架

  • 全球預測和預測測試 PESTEL 分析（政治、社會、技術、環境、法律、促進因素和限制因素）
  • 最終用途產業分析
  • 全球預測與預測測試市場：成長率分析
  • 全球預測與預測測試市場表現：規模與成長，2019-2024 年
  • 全球預測測試市場預測：規模與成長，2024-2029 年，2034 年
  • 全球預測與預測測試總目標市場（TAM）

第6章市場區隔

  • 全球預測測試市場（按測試類型、效能和預測）2019-2024 年、2024-2029 年、2034 年
  • 預測測試
  • 症狀前檢查
  • 全球預測測試市場：按應用、效能和預測，2019-2024 年、2024-2029 年、2034 年
  • 癌症基因檢測
  • 心血管基因檢測
  • 神經系統基因檢測
  • 其他用途
  • 全球預測測試市場：按最終用戶、績效和預測，2019-2024 年、2024-2029 年、2034 年
  • 醫院和診所
  • 診斷實驗室
  • 研究組織
  • 其他最終用戶
  • 全球預測測試市場預測細分（按測試類型、實際和預測），2019-2024 年、2024-2029 年、2034 年
  • 遺傳疾病的基因檢測
  • 癌症風險預測
  • 預測心血管疾病
  • 神經退化性疾病風險預測
  • 體染色體顯性遺傳疾病的基因篩檢
  • 產前預測測試
  • 藥物基因組學檢測
  • 全球預測和預測測試市場，按測試類型、表現和預測對症狀前測試進行細分，2019-2024 年、2024-2029 年、2034 年
  • 亨丁頓舞蹈症檢測
  • 遺傳性癌症風險檢測
  • 囊腫纖維化的症狀前檢測
  • 早發性阿茲海默症檢測
  • 遺傳疾病攜帶者篩檢
  • 檢測神經退化性疾病的早期徵兆
  • 遺傳性疾病的症狀前基因檢測

第7章 區域和國家分析

  • 全球預測測試市場：按地區、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 全球預測測試市場：依國家、表現及預測，2019-2024 年、2024-2029 年、2034 年

第8章 亞太市場

第9章：中國市場

第10章 印度市場

第11章 日本市場

第12章 澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章 西歐市場

第16章英國市場

第17章 德國市場

第18章 法國市場

第19章：義大利市場

第20章：西班牙市場

第21章 東歐市場

第22章 俄羅斯市場

第23章 北美市場

第24章美國市場

第25章：加拿大市場

第26章 南美洲市場

第27章：巴西市場

第28章 中東市場

第29章：非洲市場

第30章競爭格局與公司概況

  • 預測與預測測試市場：競爭格局
  • 預測與預測測試市場：公司簡介
    • F. Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis
    • Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Mayo Clinic Overview, Products and Services, Strategy and Financial Analysis
    • Quest Diagnostics Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Illumina Inc. Overview, Products and Services, Strategy and Financial Analysis

第31章 其他大型創新企業

  • Bio-Rad Laboratories Inc.
  • Qiagen NV
  • Peter MacCallum Cancer Centre
  • Myriad Genetics Inc.
  • SomaLogic Inc.
  • Siteman Cancer Center
  • Dante Labs SRL
  • Mapmygenome
  • Manipal Health Enterprises
  • Gene Vision
  • Reliance Diagnostic
  • GenepoweRx
  • Personal Genomics
  • Apollo Hospitals Enterprise Limited
  • Cardio Diagnostics Inc.

第 32 章全球市場競爭基準化分析與儀表板

第33章 重大併購

第34章近期市場趨勢

第 35 章 高市場潛力國家、細分市場與策略

  • 2029 年預測與預測測試市場：提供新機會的國家
  • 2029 年預測與預測測試市場：細分市場將帶來新機會
  • 2029 年預測與預測測試市場：成長策略
    • 基於市場趨勢的策略
    • 競爭對手的策略

第36章 附錄

簡介目錄
Product Code: r33524

Predictive and presymptomatic testing are genetic tests aimed at evaluating an individual's likelihood of developing a disease before any symptoms appear, particularly for inherited conditions. These tests help identify individuals at a higher risk for specific genetic disorders, allowing for early intervention and personalized care. The advantages include early diagnosis, customized prevention strategies, and more informed lifestyle decisions.

The primary forms of testing are predictive and presymptomatic. Predictive testing determines whether an individual has a genetic predisposition to develop a specific condition or disease in the future, even if they currently have no symptoms. Applications include cancer genetic testing, cardiovascular genetic testing, neurological genetic testing, and more. These tests are used by hospitals and clinics, diagnostic laboratories, research institutes, and other healthcare providers.

The predictive and presymptomatic testing market research report is one of a series of new reports from The Business Research Company that provides predictive and presymptomatic testing market statistics, including predictive and presymptomatic testing industry global market size, regional shares, competitors with a predictive and presymptomatic testing market share, detailed predictive and presymptomatic testing market segments, market trends and opportunities, and any further data you may need to thrive in the predictive and presymptomatic testing industry. This predictive and presymptomatic testing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The predictive and presymptomatic testing market size has grown rapidly in recent years. It will grow from $5.24 billion in 2024 to $5.78 billion in 2025 at a compound annual growth rate (CAGR) of 10.3%. The growth in the historic period can be attributed to increasing incidence of genetic disorders, rising demand for early diagnosis of chronic diseases, rising prevalence of cancer, increasing adoption of personalized medicine, increasing availability of direct-to-consumer genetic tests.

The predictive and presymptomatic testing market size is expected to see rapid growth in the next few years. It will grow to $8.47 billion in 2029 at a compound annual growth rate (CAGR) of 10.1%. The growth in the forecast period can be attributed to increasing demand for early disease detection, increasing investments in biotechnology and genomics, rising demand for non-invasive testing methods, growth in the geriatric population, growth in precision medicine initiatives. Major trends in the forecast period include adoption of personalized medicine, adoption of home testing kits, integration of genomics and big data, development of next generation sequencing (NGS) technologies, implementation of predictive testing in drug development.

The growing prevalence of genetic disorders is expected to drive the expansion of the predictive and presymptomatic testing market in the future. Genetic disorders, caused by abnormalities in deoxyribonucleic acid (DNA) such as gene mutations and chromosome changes, include conditions like cystic fibrosis and Down syndrome. Factors contributing to the increasing incidence of these disorders include advanced maternal age, environmental influences, and improved diagnostic techniques. Predictive and presymptomatic testing is essential in reducing the occurrence of genetic disorders by identifying individuals at risk before symptoms appear. This proactive strategy enables early interventions or lifestyle changes that can help prevent or lessen the severity of these conditions. For example, in June 2023, the American Society of Gene and Cell Therapy, a US-based non-profit medical and scientific organization, reported a 10% increase in the number of gene therapies in Phase III clinical trials in the third quarter of 2023, marking the first quarterly rise since the third quarter of 2022. Thus, the increasing prevalence of genetic disorders is fueling the growth of the predictive and presymptomatic testing market.

Key companies in the predictive and presymptomatic testing market are prioritizing technological advancements, such as microbiome-driven predictive models, to improve early detection and offer personalized health insights. These predictive models utilize microbiome data to anticipate potential health issues and enhance early diagnosis. For example, in December 2023, Genefitletics, an Indian biotechnology firm, introduced vascomath, a groundbreaking cardiovascular disease (CVD) prediction model. This model leverages gene expression data from the gut and oral microbiome to detect cardiovascular risks early. It integrates with existing predictive models and provides precision nutrition interventions, representing a major innovation in predictive and presymptomatic testing.

In November 2022, Myriad Genetics, a US-based biotechnology company, acquired Gateway Genomics for an undisclosed sum. This acquisition aims to broaden Myriad's genetic testing portfolio and strengthen its position in the consumer genetics market. Gateway Genomics, also a US-based biotechnology firm, specializes in direct-to-consumer genetic testing and reproductive health solutions.

Major companies operating in the predictive and presymptomatic testing market are F. Hoffmann-La Roche AG, Thermo Fisher Scientific Inc., Mayo Clinic, Quest Diagnostics Inc., Illumina Inc., Bio-Rad Laboratories Inc., Qiagen N.V., Peter MacCallum Cancer Centre, Myriad Genetics Inc., SomaLogic Inc., Siteman Cancer Center, Dante Labs S.R.L., Mapmygenome, Manipal Health Enterprises, Gene Vision, Reliance Diagnostic, GenepoweRx, Personal Genomics, Apollo Hospitals Enterprise Limited, Cardio Diagnostics Inc.

North America was the largest region in the predictive and presymptomatic testing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the predictive and presymptomatic testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the predictive and presymptomatic testing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The predictive and presymptomatic testing market consists of revenues earned by entities by providing services such as genetic testing, risk assessment, early disease detection, biomarker testing, and predictive modelling. The market value includes the value of related goods sold by the service provider or included within the service offering. The predictive and presymptomatic testing market also includes sales of carrier screening tests, genetic tests, diagnostic tools, prenatal testing kits, and Alzheimer's disease biomarkers. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Predictive And Presymptomatic Testing Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on predictive and presymptomatic testing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for predictive and presymptomatic testing ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The predictive and presymptomatic testing market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Test Type: Predictive Testing; Presymptomatic Testing
  • 2) By Application: Cancer Genetic Testing; Cardiovascular Genetic Testing; Neurological Genetic Testing; Other Applications
  • 3) By End User: Hospitals And Clinics; Diagnostic Laboratories; Research Institutes; Other End Users
  • Subsegments:
  • 1) By Predictive Testing: Genetic Testing for Inherited Conditions; Cancer Risk Prediction; Cardiovascular Disease Prediction; Neurodegenerative Disease Risk Prediction; Genetic Screening for Autosomal Dominant Disorders; Prenatal Predictive Testing; Pharmacogenomic Testing
  • 2) By Presymptomatic Testing: Huntington's Disease Testing; Hereditary Cancer Risk Testing; Cystic Fibrosis Presymptomatic Testing; Early-Onset Alzheimer's Disease Testing; Carrier Screening for Genetic Conditions; Testing for Early Signs of Neurodegenerative Diseases; Presymptomatic Genetic Testing for Familial Diseases
  • Companies Mentioned: F. Hoffmann-La Roche AG; Thermo Fisher Scientific Inc.; Mayo Clinic; Quest Diagnostics Inc.; Illumina Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Predictive And Presymptomatic Testing Market Characteristics

3. Predictive And Presymptomatic Testing Market Trends And Strategies

4. Predictive And Presymptomatic Testing Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Predictive And Presymptomatic Testing Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Predictive And Presymptomatic Testing PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Predictive And Presymptomatic Testing Market Growth Rate Analysis
  • 5.4. Global Predictive And Presymptomatic Testing Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Predictive And Presymptomatic Testing Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Predictive And Presymptomatic Testing Total Addressable Market (TAM)

6. Predictive And Presymptomatic Testing Market Segmentation

  • 6.1. Global Predictive And Presymptomatic Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Predictive Testing
  • Presymptomatic Testing
  • 6.2. Global Predictive And Presymptomatic Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Cancer Genetic Testing
  • Cardiovascular Genetic Testing
  • Neurological Genetic Testing
  • Other Applications
  • 6.3. Global Predictive And Presymptomatic Testing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals And Clinics
  • Diagnostic Laboratories
  • Research Institutes
  • Other End Users
  • 6.4. Global Predictive And Presymptomatic Testing Market, Sub-Segmentation Of Predictive Testing, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Genetic Testing for Inherited Conditions
  • Cancer Risk Prediction
  • Cardiovascular Disease Prediction
  • Neurodegenerative Disease Risk Prediction
  • Genetic Screening for Autosomal Dominant Disorders
  • Prenatal Predictive Testing
  • Pharmacogenomic Testing
  • 6.5. Global Predictive And Presymptomatic Testing Market, Sub-Segmentation Of Presymptomatic Testing, By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Huntington's Disease Testing
  • Hereditary Cancer Risk Testing
  • Cystic Fibrosis Presymptomatic Testing
  • Early-Onset Alzheimer's Disease Testing
  • Carrier Screening for Genetic Conditions
  • Testing for Early Signs of Neurodegenerative Diseases
  • Presymptomatic Genetic Testing for Familial Diseases

7. Predictive And Presymptomatic Testing Market Regional And Country Analysis

  • 7.1. Global Predictive And Presymptomatic Testing Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Predictive And Presymptomatic Testing Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Predictive And Presymptomatic Testing Market

  • 8.1. Asia-Pacific Predictive And Presymptomatic Testing Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Predictive And Presymptomatic Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Predictive And Presymptomatic Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Predictive And Presymptomatic Testing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Predictive And Presymptomatic Testing Market

  • 9.1. China Predictive And Presymptomatic Testing Market Overview
  • 9.2. China Predictive And Presymptomatic Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Predictive And Presymptomatic Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Predictive And Presymptomatic Testing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Predictive And Presymptomatic Testing Market

  • 10.1. India Predictive And Presymptomatic Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Predictive And Presymptomatic Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Predictive And Presymptomatic Testing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Predictive And Presymptomatic Testing Market

  • 11.1. Japan Predictive And Presymptomatic Testing Market Overview
  • 11.2. Japan Predictive And Presymptomatic Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Predictive And Presymptomatic Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Predictive And Presymptomatic Testing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Predictive And Presymptomatic Testing Market

  • 12.1. Australia Predictive And Presymptomatic Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Predictive And Presymptomatic Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Predictive And Presymptomatic Testing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Predictive And Presymptomatic Testing Market

  • 13.1. Indonesia Predictive And Presymptomatic Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Predictive And Presymptomatic Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Predictive And Presymptomatic Testing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Predictive And Presymptomatic Testing Market

  • 14.1. South Korea Predictive And Presymptomatic Testing Market Overview
  • 14.2. South Korea Predictive And Presymptomatic Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Predictive And Presymptomatic Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Predictive And Presymptomatic Testing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Predictive And Presymptomatic Testing Market

  • 15.1. Western Europe Predictive And Presymptomatic Testing Market Overview
  • 15.2. Western Europe Predictive And Presymptomatic Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Predictive And Presymptomatic Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Predictive And Presymptomatic Testing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Predictive And Presymptomatic Testing Market

  • 16.1. UK Predictive And Presymptomatic Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Predictive And Presymptomatic Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Predictive And Presymptomatic Testing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Predictive And Presymptomatic Testing Market

  • 17.1. Germany Predictive And Presymptomatic Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Predictive And Presymptomatic Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Predictive And Presymptomatic Testing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Predictive And Presymptomatic Testing Market

  • 18.1. France Predictive And Presymptomatic Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Predictive And Presymptomatic Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Predictive And Presymptomatic Testing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Predictive And Presymptomatic Testing Market

  • 19.1. Italy Predictive And Presymptomatic Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Predictive And Presymptomatic Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Predictive And Presymptomatic Testing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Predictive And Presymptomatic Testing Market

  • 20.1. Spain Predictive And Presymptomatic Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Predictive And Presymptomatic Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Predictive And Presymptomatic Testing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Predictive And Presymptomatic Testing Market

  • 21.1. Eastern Europe Predictive And Presymptomatic Testing Market Overview
  • 21.2. Eastern Europe Predictive And Presymptomatic Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Predictive And Presymptomatic Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Predictive And Presymptomatic Testing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Predictive And Presymptomatic Testing Market

  • 22.1. Russia Predictive And Presymptomatic Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Predictive And Presymptomatic Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Predictive And Presymptomatic Testing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Predictive And Presymptomatic Testing Market

  • 23.1. North America Predictive And Presymptomatic Testing Market Overview
  • 23.2. North America Predictive And Presymptomatic Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Predictive And Presymptomatic Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Predictive And Presymptomatic Testing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Predictive And Presymptomatic Testing Market

  • 24.1. USA Predictive And Presymptomatic Testing Market Overview
  • 24.2. USA Predictive And Presymptomatic Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Predictive And Presymptomatic Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Predictive And Presymptomatic Testing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Predictive And Presymptomatic Testing Market

  • 25.1. Canada Predictive And Presymptomatic Testing Market Overview
  • 25.2. Canada Predictive And Presymptomatic Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Predictive And Presymptomatic Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Predictive And Presymptomatic Testing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Predictive And Presymptomatic Testing Market

  • 26.1. South America Predictive And Presymptomatic Testing Market Overview
  • 26.2. South America Predictive And Presymptomatic Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Predictive And Presymptomatic Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Predictive And Presymptomatic Testing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Predictive And Presymptomatic Testing Market

  • 27.1. Brazil Predictive And Presymptomatic Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Predictive And Presymptomatic Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Predictive And Presymptomatic Testing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Predictive And Presymptomatic Testing Market

  • 28.1. Middle East Predictive And Presymptomatic Testing Market Overview
  • 28.2. Middle East Predictive And Presymptomatic Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Predictive And Presymptomatic Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Predictive And Presymptomatic Testing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Predictive And Presymptomatic Testing Market

  • 29.1. Africa Predictive And Presymptomatic Testing Market Overview
  • 29.2. Africa Predictive And Presymptomatic Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Predictive And Presymptomatic Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Predictive And Presymptomatic Testing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Predictive And Presymptomatic Testing Market Competitive Landscape And Company Profiles

  • 30.1. Predictive And Presymptomatic Testing Market Competitive Landscape
  • 30.2. Predictive And Presymptomatic Testing Market Company Profiles
    • 30.2.1. F. Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Mayo Clinic Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Quest Diagnostics Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Illumina Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Predictive And Presymptomatic Testing Market Other Major And Innovative Companies

  • 31.1. Bio-Rad Laboratories Inc.
  • 31.2. Qiagen N.V.
  • 31.3. Peter MacCallum Cancer Centre
  • 31.4. Myriad Genetics Inc.
  • 31.5. SomaLogic Inc.
  • 31.6. Siteman Cancer Center
  • 31.7. Dante Labs S.R.L.
  • 31.8. Mapmygenome
  • 31.9. Manipal Health Enterprises
  • 31.10. Gene Vision
  • 31.11. Reliance Diagnostic
  • 31.12. GenepoweRx
  • 31.13. Personal Genomics
  • 31.14. Apollo Hospitals Enterprise Limited
  • 31.15. Cardio Diagnostics Inc.

32. Global Predictive And Presymptomatic Testing Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Predictive And Presymptomatic Testing Market

34. Recent Developments In The Predictive And Presymptomatic Testing Market

35. Predictive And Presymptomatic Testing Market High Potential Countries, Segments and Strategies

  • 35.1 Predictive And Presymptomatic Testing Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Predictive And Presymptomatic Testing Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Predictive And Presymptomatic Testing Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer
  • 250423_r33524_Predictive_And_Presymptomatic_Testing_GMR_2025